COMMUNIQUÉS West-GlobeNewswire

Pacific Health Care Organization, Inc. First Quarter 2019 Results
21/05/2019
Newport Beach, CA, May 20, 2019 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its quarterly report [...]
Akers Biosciences Reports Q1 2019 Earnings
20/05/2019
Continued Progress Toward Positioning the Company for Strategic Alternatives THOROFARE, N.J., May 20, 2019 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (“Akers Bio” or the “Company”), a developer of rapid [...]
CorVel Announces Fiscal Year Earnings Release Webcast
20/05/2019
IRVINE, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- Event: Fiscal Year Earnings Release Webcast Hosts: Michael Combs, President and Chief Executive Officer Brandon O’Brien, Chief Financial Officer Date: Thursday, May 30, [...]
Cancer Genetics Reports First Quarter 2019 Financial Results and Provides Strategic Business Update
20/05/2019
RUTHERFORD, N.J., May 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through diagnostics, molecular markers and data [...]
Voyager Therapeutics Announces Management Updates
20/05/2019
CAMBRIDGE, Mass., May 20, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]
SIGA Announces Exercise of Option for the Purchase of Raw Materials for Oral TPOXX® Manufacturing Totaling $11 Million
20/05/2019
Raw Materials expected to be used to Support Manufacture of 363,070 Courses of Oral TPOXX NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical [...]
B. Braun Interventional Systems Announces U.S. Commercial Launch of NuDEL™ All-in-One Stent Delivery System for Treatment of Congenital Heart Defects
20/05/2019
BETHLEHEM, Pa., May 20, 2019 (GLOBE NEWSWIRE) -- B. Braun Interventional Systems Inc. (BIS) in collaboration with NuMED Inc. announced today the U.S. launch of the NuDEL™ CP Stent ® Delivery System, intended for the [...]
Guardant Health, Inc. Announces Proposed Public Offering of Common Stock
20/05/2019
REDWOOD CITY, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq:GH), a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast [...]
Akorn Receives FDA Approval for Azelastine Hydrochloride Nasal Spray, 0.1%
20/05/2019
LAKE FOREST, Ill., May 20, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) approval [...]
Emergent BioSolutions Announces Granting of Marketing Authorization in Five EU Countries for Its Oral Typhoid Vaccine; Expands Availability Across Europe
20/05/2019
GAITHERSBURG, Md., May 20, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has successfully obtained marketing authorization for its oral typhoid vaccine Vivotif ® (Typhoid [...]
HOOKIPA Pharma Reports First Quarter 2019 Financial Results and Recent Business Highlights
20/05/2019
NEW YORK and VIENNA, Austria, May 20, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (“HOOKIPA”), a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on its proprietary [...]
CymaBay Therapeutics Presents Data in Patients with Primary Biliary Cholangitis at DDW 2019
20/05/2019
NEWARK, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on developing and providing access to innovative therapies for patients with liver and [...]
Align Technology General Counsel Retires After 17 Years, Appoints Julie Coletti SVP Chief Legal and Regulatory Officer
20/05/2019
SAN JOSE, Calif., May 20, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), today announced that Roger E. George, Align senior vice president, chief legal and regulatory officer has retired and will leave [...]
AzurRx BioPharma Presents Positive Secondary Endpoint Data in its Phase II MS1819-SD Chronic Pancreatitis Study at the 2019 Digestive Disease Week Conference
20/05/2019
Statistical significance achieved on multiple secondary endpoints New data underscore the potential of MS1819 to provide meaningful clinical benefits to patients suffering from exocrine pancreatic insufficiency (EPI) [...]
Can-Fite BioPharma Announces $6 Million Registered Direct Offering
20/05/2019
PETACH TIKVA, Israel, May 20, 2019 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI) , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, [...]
HX Global SVP of Business Operations Attends Event Hosted by HRH Prince Charles of Wales
20/05/2019
Tim Crockett was present for the launch of HRH appeal to raise £10 million for Combat Stress LONDON, May 20, 2019 (GLOBE NEWSWIRE) -- HX Global’s Senior Vice President of Operations, Tim Crockett, had the honor of being [...]
Athersys Presents Data From Its Acute Respiratory Distress Syndrome Clinical Trial at American Thoracic Society International Conference
20/05/2019
The MultiStem® treatment group had more ventilator-free and ICU-free days, and greater reduction in acute inflammatory biomarkers compared to the placebo CLEVELAND, May 20, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. ( [...]
OSE Immunotherapeutics Receives Notice of Allowance for New U.S. Patent Protecting Anti-IL-7 Receptor Antagonist OSE-127
20/05/2019
The new patent will cover OSE-127 through 2035 NANTES, France, May 20, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) today announces that it has received the first notice of allowance [...]
Arcturus Therapeutics Presenting Data for ARCT-810 and the Arcturus mRNA + LUNAR® Technology Platform at the 2019 Annual Meeting of TIDES: Oligonucleotide and Peptide Therapeutics
20/05/2019
SAN DIEGO, May 20, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT) (the “Company”), a leading messenger RNA medicines company focused on the discovery, development and commercialization of [...]

Pages